PP

Prabuddha Pal

Active Director Director DIN 08942735
DIN 08942735 First appointment Nov 2020 Primary industry E-Commerce
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Prabuddha Pal

Data last updated:

Prabuddha Pal is a Director at Kcr Medipharma Private Limited (since 2020). The company operates in E-Commerce. Kcr Medipharma Private Limited reported revenue of ₹97,300 (FY 2024).

DIN 08942735
Primary Designation Director
Industry E-Commerce
First Appointment 13 Nov 2020
Oldest Company Age 6 yrs
Largest company Kcr Medipharma Private Limited · ₹97,300 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kcr Medipharma Private Limited U52520WB2020PTC241291
Director13 Nov 20202020₹97,300 (FY 2024)Active

Board colleagues of Prabuddha Pal

Directorship timeline

Open interactive timeline →
Kcr Medipharma Private Limited
Premium access

Shareholding and investment profile for Prabuddha Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prabuddha Pal

Prabuddha Pal currently holds 1 directorship: Kcr Medipharma Private Limited (Director, since 13 Nov 2020, revenue ₹97,300 (FY 2024)).

Prabuddha Pal was first appointed on 13 Nov 2020 as Director at Kcr Medipharma Private Limited.

The current boards of Prabuddha Pal's companies include Amartyesh Roy (Kcr Medipharma Private Limited), Himangshu Roy (Kcr Medipharma Private Limited), Shikha Roy (Kcr Medipharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available